FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288052171> ?p ?o ?g. }

• W4288052171 endingPage "e0271394" @default.
• W4288052171 startingPage "e0271394" @default.
• W4288052171 abstract "Background Understanding public discourse about a COVID-19 vaccine in the early phase of the COVID-19 pandemic may provide key insights concerning vaccine hesitancy. However, few studies have investigated the communicative patterns in which Twitter users participate discursively in vaccine discussions. Objectives This study aims to investigate 1) the major topics that emerged from public conversation on Twitter concerning vaccines for COVID-19, 2) the topics that were emphasized in tweets with either positive or negative sentiment toward a COVID-19 vaccine, and 3) the type of online accounts in which tweets with either positive or negative sentiment were more likely to circulate. Methods We randomly extracted a total of 349,979 COVID-19 vaccine-related tweets from the initial period of the pandemic. Out of 64,216 unique tweets, a total of 23,133 (36.03%) tweets were classified as positive and 14,051 (21.88%) as negative toward a COVID-19 vaccine. We conducted Structural Topic Modeling and Network Analysis to reveal the distinct topical structure and connection patterns that characterize positive and negative discourse toward a COVID-19 vaccine. Results Our STM analysis revealed the most prominent topic emerged on Twitter of a COVID-19 vaccine was “other infectious diseases”, followed by “vaccine safety concerns”, and “conspiracy theory.” While the positive discourse demonstrated a broad range of topics such as “vaccine development”, “vaccine effectiveness”, and “safety test”, negative discourse was more narrowly focused on topics such as “conspiracy theory” and “safety concerns.” Beyond topical differences, positive discourse was more likely to interact with verified sources such as scientists/medical sources and the media/journalists, whereas negative discourse tended to interact with politicians and online influencers. Conclusions Positive and negative discourse was not only structured around distinct topics but also circulated within different networks. Public health communicators need to address specific topics of public concern in varying information hubs based on audience segmentation, potentially increasing COVID-19 vaccine uptake." @default.
• W4288052171 created "2022-07-28" @default.
• W4288052171 creator A5055420216 @default.
• W4288052171 creator A5059256506 @default.
• W4288052171 creator A5067534857 @default.
• W4288052171 creator A5068570040 @default.
• W4288052171 creator A5068696786 @default.
• W4288052171 creator A5077348975 @default.
• W4288052171 date "2022-07-27" @default.
• W4288052171 modified "2023-09-30" @default.
• W4288052171 title "Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy" @default.
• W4288052171 cites W2025543856 @default.
• W4288052171 cites W2106723251 @default.
• W4288052171 cites W2114014041 @default.
• W4288052171 cites W2160909148 @default.
• W4288052171 cites W2606213316 @default.
• W4288052171 cites W2780896111 @default.
• W4288052171 cites W2806777656 @default.
• W4288052171 cites W2901331787 @default.
• W4288052171 cites W2906409579 @default.
• W4288052171 cites W2913649461 @default.
• W4288052171 cites W2922770828 @default.
• W4288052171 cites W2959736309 @default.
• W4288052171 cites W2963208184 @default.
• W4288052171 cites W2971943376 @default.
• W4288052171 cites W3006419170 @default.
• W4288052171 cites W3020062806 @default.
• W4288052171 cites W3026536348 @default.
• W4288052171 cites W3037665078 @default.
• W4288052171 cites W3045045932 @default.
• W4288052171 cites W3048848247 @default.
• W4288052171 cites W3083835905 @default.
• W4288052171 cites W3084298048 @default.
• W4288052171 cites W3093951335 @default.
• W4288052171 cites W3096058949 @default.
• W4288052171 cites W3096250258 @default.
• W4288052171 cites W3105858565 @default.
• W4288052171 cites W3106691456 @default.
• W4288052171 cites W3183221431 @default.
• W4288052171 cites W4205815337 @default.
• W4288052171 cites W4230331587 @default.
• W4288052171 doi "https://doi.org/10.1371/journal.pone.0271394" @default.
• W4288052171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35895626" @default.
• W4288052171 hasPublicationYear "2022" @default.
• W4288052171 type Work @default.
• W4288052171 citedByCount "3" @default.
• W4288052171 countsByYear W42880521712023 @default.
• W4288052171 crossrefType "journal-article" @default.
• W4288052171 hasAuthorship W4288052171A5055420216 @default.
• W4288052171 hasAuthorship W4288052171A5059256506 @default.
• W4288052171 hasAuthorship W4288052171A5067534857 @default.
• W4288052171 hasAuthorship W4288052171A5068570040 @default.
• W4288052171 hasAuthorship W4288052171A5068696786 @default.
• W4288052171 hasAuthorship W4288052171A5077348975 @default.
• W4288052171 hasBestOaLocation W42880521711 @default.
• W4288052171 hasConcept C138816342 @default.
• W4288052171 hasConcept C142724271 @default.
• W4288052171 hasConcept C15744967 @default.
• W4288052171 hasConcept C17744445 @default.
• W4288052171 hasConcept C199539241 @default.
• W4288052171 hasConcept C2777200299 @default.
• W4288052171 hasConcept C2779134260 @default.
• W4288052171 hasConcept C2992826032 @default.
• W4288052171 hasConcept C3007834351 @default.
• W4288052171 hasConcept C3008058167 @default.
• W4288052171 hasConcept C46312422 @default.
• W4288052171 hasConcept C518677369 @default.
• W4288052171 hasConcept C524204448 @default.
• W4288052171 hasConcept C71924100 @default.
• W4288052171 hasConcept C89623803 @default.
• W4288052171 hasConcept C94625758 @default.
• W4288052171 hasConceptScore W4288052171C138816342 @default.
• W4288052171 hasConceptScore W4288052171C142724271 @default.
• W4288052171 hasConceptScore W4288052171C15744967 @default.
• W4288052171 hasConceptScore W4288052171C17744445 @default.
• W4288052171 hasConceptScore W4288052171C199539241 @default.
• W4288052171 hasConceptScore W4288052171C2777200299 @default.
• W4288052171 hasConceptScore W4288052171C2779134260 @default.
• W4288052171 hasConceptScore W4288052171C2992826032 @default.
• W4288052171 hasConceptScore W4288052171C3007834351 @default.
• W4288052171 hasConceptScore W4288052171C3008058167 @default.
• W4288052171 hasConceptScore W4288052171C46312422 @default.
• W4288052171 hasConceptScore W4288052171C518677369 @default.
• W4288052171 hasConceptScore W4288052171C524204448 @default.
• W4288052171 hasConceptScore W4288052171C71924100 @default.
• W4288052171 hasConceptScore W4288052171C89623803 @default.
• W4288052171 hasConceptScore W4288052171C94625758 @default.
• W4288052171 hasFunder F4320307873 @default.
• W4288052171 hasFunder F4320308835 @default.
• W4288052171 hasIssue "7" @default.
• W4288052171 hasLocation W42880521711 @default.
• W4288052171 hasLocation W42880521712 @default.
• W4288052171 hasLocation W42880521713 @default.
• W4288052171 hasLocation W42880521714 @default.
• W4288052171 hasOpenAccess W4288052171 @default.
• W4288052171 hasPrimaryLocation W42880521711 @default.
• W4288052171 hasRelatedWork W2748952813 @default.
• W4288052171 hasRelatedWork W3017171836 @default.

• next